```html

Resistant Hypertension

What is Resistant hypertension?

Resistant hypertension (RH) is defined as blood pressure that stays above the target (≥140/90 mm Hg in most adults) despite the concurrent use of three or more antihypertensive agents of different classes, one of which should be a diuretic, at optimal doses. It can also refer to blood pressure that is controlled only with four or more medications. This condition accounts for roughly 10–20 % of all patients with hypertension and is linked to a higher risk of heart attack, stroke, kidney disease, and early death <sup>[1]</sup>.

The diagnosis of RH is one of exclusion – physicians first make sure the blood pressure readings are accurate, that the patient is adherent to therapy, and that no secondary causes are present. Because the condition is often a sign of underlying problems, a systematic work‑up is essential.

Common Causes

Several factors can make blood pressure “resistant” to treatment. The most frequent contributors are:

• Inadequate or inappropriate drug regimen – sub‑therapeutic doses, missing a diuretic, or using agents with overlapping mechanisms.
• Poor medication adherence – forgetting doses, stopping meds because of side‑effects, or cost barriers.
• Secondary hypertension – conditions that cause high blood pressure independently, such as:
  • Renal artery stenosis
  • Primary aldosteronism
  • Obstructive sleep apnea (OSA)
  • Chronic kidney disease (CKD)
  • Coarctation of the aorta
  • Pheochromocytoma
• Lifestyle factors – excessive sodium intake, high alcohol consumption, obesity, chronic stress, and sedentary behavior.
• Drug‑induced hypertension – non‑steroidal anti‑inflammatory drugs (NSAIDs), corticosteroids, oral contraceptives, decongestants, and certain antidepressants.
• White‑coat effect – elevated readings in a clinical setting but normal values at home.
• Genetic predisposition – polymorphisms that affect the renin‑angiotensin‑aldosterone system (RAAS) or sympathetic tone.
• Volume overload – often due to hidden fluid retention in patients with heart failure or CKD.
• Sympathetic overactivity – seen in conditions such as chronic pain, anxiety disorders, or untreated OSA.

Associated Symptoms

Resistant hypertension itself may be silent, but many patients experience symptoms related to the underlying cause or to the high pressure on organs:

• Headaches, especially in the morning
• Dizziness or light‑headedness
• Blurred vision or visual changes
• Chest discomfort or angina
• Shortness of breath on exertion
• Swelling of the ankles or feet (edema)
• Frequent nighttime urination (nocturia)
• Fatigue or generalized weakness
• Snoring, gasping, or observed apneas during sleep (suggesting OSA)

When to See a Doctor

Prompt medical attention is advisable if you notice any of the following:

• Blood pressure remains ≥140/90 mm Hg despite using three antihypertensive drugs (including a diuretic).
• Sudden increase in home or office BP readings.
• New or worsening headache, visual changes, or chest pain.
• Signs of fluid overload (rapid weight gain, swelling, shortness of breath).
• Persistent pounding or racing heartbeats (palpitations).
• Any symptoms suggestive of a secondary cause (e.g., loud snoring, flank pain, unexplained muscle weakness).

Because resistant hypertension raises the risk of cardiovascular events, early evaluation can prevent complications.

Diagnosis

Evaluating RH is a stepwise process that combines careful history, physical exam, and targeted testing.

1. Confirm Accurate Blood Pressure Measurement

• Use a validated automated cuff, correct cuff size, and have the patient seated quietly for 5 minutes.
• Obtain at least two readings on two separate occasions.
• Consider 24‑hour ambulatory BP monitoring (ABPM) or home BP monitoring to rule out white‑coat hypertension.

2. Review Medication Adherence & Lifestyle

• Ask directly about missed doses, side‑effects, and cost issues.
• Check for over‑the‑counter drugs, supplements, and dietary sodium.

**Key Tests**

• Basic labs: CBC, electrolytes, fasting glucose, lipid profile, creatinine, eGFR, urinalysis.
• Renal ultrasound or CT angiography: to look for renal artery stenosis.
• Plasma aldosterone/renin ratio: screening for primary aldosteronism.
• Sleep study (polysomnography): if obstructive sleep apnea is suspected.
• Echocardiogram: assesses left‑ventricular hypertrophy or heart failure.
• Urinary catecholamines or metanephrines: when pheochromocytoma is a consideration.

3. Evaluate for Secondary Causes

Guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA) recommend a focused work‑up based on clinical clues (e.g., hypokalemia suggesting aldosteronism, abdominal bruit hinting at renal artery stenosis) <sup>[2]</sup>.

Treatment Options

Management combines optimization of drug therapy, addressing reversible causes, and lifestyle modification.

1. Pharmacologic Strategies

• Optimized diuretic therapy – usually a thiazide‑type (hydrochlorothiazide or chlorthalidone) or a loop diuretic in patients with CKD.
• Renin‑angiotensin system blockade – ACE inhibitor or ARB; consider adding a direct renin inhibitor if needed.
• Calcium‑channel blocker – amlodipine or nifedipine are effective for most patients.
• Add‑on agents for truly resistant cases:
  • Spironolactone (or eplerenone) – first‑line add‑on for its mineralocorticoid antagonism.
  • Beta‑blockers – especially if there is concomitant coronary disease or tachyarrhythmia.
  • Alpha‑blockers (e.g., doxazosin) – useful in select patients.
  • Central acting agents (e.g., clonidine) – for refractory cases.
  • Renal denervation – an emerging interventional option; consider for patients who fail maximal medical therapy and have confirmed secondary sympathetic overactivity.

2. Treat Underlying/Secondary Causes

• Renal artery stenosis – percutaneous angioplasty with stenting or surgical revascularization.
• Primary aldosteronism – surgical adrenalectomy or mineralocorticoid‑receptor antagonists.
• Obstructive sleep apnea – continuous positive airway pressure (CPAP) therapy markedly lowers BP.
• CKD – careful fluid management, ACEi/ARB, and low‑protein diet when indicated.
• Discontinue or replace offending drugs (NSAIDs, steroids, decongestants, etc.).

3. Lifestyle & Home Measures

• Dietary sodium restriction – aim for < 1500 mg/day (≈ 3.5 g salt). The DASH diet is strongly supported by evidence <sup>[3]</sup>.
• Weight loss – 5–10 % reduction in body weight can lower systolic BP by 5–20 mm Hg.
• Regular aerobic activity – ≥150 minutes/week of moderate‑intensity exercise.
• Limit alcohol – ≤2 drinks/day for men, ≤1 drink/day for women.
• Stress reduction – mindfulness, yoga, or CBT can modestly improve BP.
• Home BP monitoring – helps assess medication efficacy and adherence.

Prevention Tips

While certain secondary causes cannot always be avoided, many elements that lead to resistant hypertension are modifiable:

• Maintain a healthy weight (BMI < 25 kg/m²).
• Adopt the DASH eating pattern with plenty of fruits, vegetables, whole grains, low‑fat dairy, and lean protein.
• Keep sodium intake low; read food labels and avoid processed meats, canned soups, and fast food.
• Exercise regularly; incorporate both aerobic and resistance training.
• Limit caffeine and alcohol, and stop smoking.
• Take prescribed antihypertensives exactly as directed; use pill boxes or phone reminders.
• Schedule routine follow‑up visits to re‑evaluate therapy and screen for secondary causes.
• Screen for sleep apnea if you snore loudly, feel unrefreshed after sleep, or are overweight.

Emergency Warning Signs

Key Take‑aways

• Resistant hypertension is high blood pressure that remains uncontrolled despite three well‑chosen drugs, including a diuretic.
• Common contributors include poor adherence, suboptimal regimens, secondary causes (renal artery stenosis, primary aldosteronism, sleep apnea), lifestyle factors, and drug‑induced elevations.
• Accurate measurement, medication review, and targeted testing are essential to rule out reversible factors.
• Effective treatment blends optimized pharmacotherapy (often adding a mineralocorticoid antagonist), management of any secondary disease, and rigorous lifestyle changes.
• Patients should monitor their BP at home, stay adherent, and seek care promptly for warning signs or emergency symptoms.

---

References:

1. Mayo Clinic. “Resistant hypertension.” Accessed May 2024. https://www.mayoclinic.org
2. American College of Cardiology/American Heart Association. 2023 Guideline for the Management of Hypertension. JACC. 2023;71:e123‑e231.
3. National Heart, Lung, and Blood Institute. “DASH Eating Plan.” Updated 2023. https://www.nhlbi.nih.gov
4. World Health Organization. “Hypertension.” Fact sheet, 2022. https://www.who.int
5. Cleveland Clinic. “Resistant Hypertension: Causes and Treatment.” 2024. https://my.clevelandclinic.org

```